• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

CMA Controversy Over MED Commentary

Credit: Wellcome Library, London. Wellcome Images images@wellcome.ac.uk http://wellcomeimages.org A group of doctors fighting. Stipple engraving, 1785. 1785 Published: 28 November 1785 Copyrighted work available under Creative Commons Attribution only licence CC BY 4.0 http://creativecommons.org/licenses/by/4.0/

By Jesse Staniforth
08/24/2019 07:41 AM GMT-0700
FacebookTweetPin

The Canadian Medical Association courted controversy with another canna-conservative editorial in its magazine CMAJ. (CMAJ provoked argument in October when it published an editorial protesting legalization.)

  • In the new opinion piece, three rheumatology MDs address sensible concerns such as lack of reliable clinical evidence about the effect of MED on various conditions, the politicization of a medical subject, and the power of MED corporations to influence public perception of . . .

    Log in or become a WeedWeek Member to read this article.

Share:
FacebookTweetPin
Filed Under:
Medical Marijuana

Primary Sidebar

Upcoming Webinar

Growth in a Tight Market

WeedWeek Wonks: The Accounts Receivable Crisis

Duration May 14th @ 1pm EST
Speakers Adam Stettner, Brett Gelfand, Alex Halperin

RSVP NOW

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Medical Marijuana Articles
lawmakers
Gavin Newsom

Newsbrief: Newsom’s MED bill veto sparks anger

The Promise of Ketamine as a Rapid-Acting Antidepressant
Sponsored

The Promise of Ketamine as a Rapid-Acting Antidepressant

Former TMS CEO joins Beyond Marketing as Medical and Education Director
Sponsored

Former TMS CEO joins Beyond Marketing as Medical and Education Director

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved